We are live on ! Find out more
GCM

Goldman Capital Management Portfolio holdings

AUM $103M
1-Year Est. Return 21.37%
This Fund
S&P 500
This Quarter Est. Return
+20.01%
1 Year Est. Return
+21.37%
3 Year Est. Return
+24.28%
5 Year Est. Return
10 Year Est. Return
AUM
$104M
AUM Growth
-$11.1M
Cap. Flow
-$10.6M
Cap. Flow %
-10.14%
Top 10 Hldgs %
86.81%
Holding
31
New
4
Increased
3
Reduced
20
Closed
1

Sector Composition

Rank Sector Weight
1 Technology 42.14%
2 Communication Services 2.65%
3 Healthcare 2.53%
4 Consumer Discretionary 1.29%
5 Financials 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IW
1
DELISTED
IMAGEWARE SYSTEMS,INC
IW
$38.1M 36.52%
36,254,716
-674,761
-2% -$708K
AAOI icon
2
Applied Optoelectronics
AAOI
$8.04B
$13.9M 13.35%
247,808
-144,692
-37% -$5.71M
ACTA
3
DELISTED
Actua Corp
ACTA
$10.5M 10.03%
744,144
-113,156
-13% -$1.59M
TRAK icon
4
ReposiTrak
TRAK
$148M
$6.3M 6.05%
510,441
-147,870
-22% -$2.04M
MATR
5
DELISTED
Mattersight Corp.
MATR
$5.41M 5.19%
1,545,263
-71,257
-4% -$260K
CYRN
6
DELISTED
CYREN Ltd.
CYRN
$5.13M 4.93%
128,347
-8,858
-6% -$366K
REFR icon
7
Research Frontiers
REFR
$16.1M
$3.02M 2.9%
2,158,091
-109,909
-5% -$189K
STGW icon
8
Stagwell
STGW
$1.84B
$2.69M 2.59%
286,700
-68,850
-19% -$542K
APPS icon
9
Digital Turbine
APPS
$1.02B
$1.92M 1.84%
2,040,000
+598,190
+41% +$469K
DTRM
10
DELISTED
Determine, Inc. Common Stock
DTRM
$1.72M 1.65%
504,539
-29,316
-5% -$78.6K
CTHR
11
DELISTED
Charles & Colvard Ltd
CTHR
$1.34M 1.29%
139,867
-10,800
-7% -$111K
MLSS icon
12
Milestone Scientific
MLSS
$34.5M
$1.3M 1.25%
965,810
+93,408
+11% +$131K
TRIB
13
Trinity Biotech
TRIB
$5.7M
$979K 0.94%
1,095
-653
-37% -$613K
IPAS
14
DELISTED
Ipass Inc Common Stock
IPAS
$937K 0.9%
80,100
+20,000
+33% +$273K
SFE
15
DELISTED
Safeguard Scientifics, Inc.
SFE
$823K 0.79%
+64,770
New +$816K
PRKR
16
DELISTED
Parkervision Inc
PRKR
$416K 0.4%
+208,800
New +$444K
PURE
17
DELISTED
PURE BIOSCIENCE INC COM STK NEW (DE)
PURE
$405K 0.39%
393,250
-43,278
-10% -$44.6K
BIOC
18
DELISTED
Biocept, Inc.
BIOC
$213K 0.2%
11
-14
-56% -$238K
XTNT icon
19
Xtant Medical Holdings
XTNT
$60.1M
$137K 0.13%
18,417
-38,465
-68% -$236K
PRSO icon
20
Peraso
PRSO
$10.3M
$110K 0.11%
66
-29
-31% -$58.1K
CXDO icon
21
Crexendo
CXDO
$215M
$63K 0.06%
42,543
-22,457
-35% -$33.3K

Similar funds

Goldman Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Goldman Capital Management held 31 positions worth $104M, down 9.6% from $115M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Goldman Capital Management withdrew a net $10.6M in Q1 2017, closing 1 position and reducing 20 holdings. Its largest reduction was Applied Optoelectronics, cutting an estimated $5.71M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 37% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Goldman Capital Management opened a new position in Safeguard Scientifics, Inc. worth $823K.

  • Goldman Capital Management's largest Q1 2017 buy was Safeguard Scientifics, Inc.: 64,770 shares worth $823K.
  • Goldman Capital Management added most to Digital Turbine in Q1 2017, an estimated $469K increase.
  • Goldman Capital Management's biggest Q1 2017 reduction was Applied Optoelectronics, cutting an estimated $5.71M.
  • Goldman Capital Management's ten largest holdings make up 87% of its $104M portfolio in Q1 2017.
  • Goldman Capital Management opened 4 new positions and closed 1 in Q1 2017.
  • Goldman Capital Management's portfolio value fell 9.6% quarter-over-quarter to $104M.

Based on Goldman Capital Management's 13F filing for Q1 2017, filed 9 May 2017.